昆明積(ji)大制藥股份有限公司成立(li)于1993年8月8日(ri)。
積(ji)大(da)(da)(da)制藥(yao)(yao)的現代化生產(chan)(chan)基地(di)位于云南省發(fa)展高(gao)新技(ji)(ji)術(shu)產(chan)(chan)業(ye)的基地(di)和外(wai)向型經(jing)濟的重要窗口(kou)——昆明國家高(gao)新技(ji)(ji)術(shu)產(chan)(chan)業(ye)開發(fa)區,占地(di)面(mian)積(ji)70畝(mu),建筑面(mian)積(ji)5萬平方(fang)米。目(mu)前,積(ji)大(da)(da)(da)制藥(yao)(yao)旗(qi)下子公(gong)(gong)司包括:專(zhuan)注于銷(xiao)售的昆明積(ji)大(da)(da)(da)藥(yao)(yao)品銷(xiao)售有限公(gong)(gong)司;著眼于國際(ji)化醫藥(yao)(yao)原料(liao)(liao)的無錫積(ji)大(da)(da)(da)制藥(yao)(yao)有限公(gong)(gong)司;從事醫藥(yao)(yao)原料(liao)(liao)及(ji)藥(yao)(yao)品進(jin)出(chu)口(kou)業(ye)務的積(ji)大(da)(da)(da)醫藥(yao)(yao)(香(xiang)港)貿易有限公(gong)(gong)司,以及(ji)蘊含(han)高(gao)新科技(ji)(ji)項目(mu)的云南積(ji)華生物科技(ji)(ji)有限公(gong)(gong)司,構建了集制劑(ji)生產(chan)(chan)、原料(liao)(liao)生產(chan)(chan)、科研(yan)、銷(xiao)售為一體的集團化模式。
良(liang)(liang)好而彈性的(de)生(sheng)產(chan)能力是積大(da)制(zhi)藥(yao)賴以實現企(qi)(qi)業(ye)戰略的(de)核心(xin)。制(zhi)劑(ji)(ji)生(sheng)產(chan)基地現有(you)十三個(ge)車間、十六條(tiao)生(sheng)產(chan)線,全部通(tong)過國(guo)家GMP認(ren)證,部分車間通(tong)過了國(guo)際市場的(de)藥(yao)品(pin)認(ren)證資質。粉針(zhen)、水(shui)針(zhen)、片劑(ji)(ji)、膠囊劑(ji)(ji)、顆粒劑(ji)(ji)、混懸劑(ji)(ji)、預灌(guan)注等多(duo)個(ge)系列40多(duo)個(ge)品(pin)種(zhong)在這具有(you)強大(da)綜合(he)優勢(shi)的(de)優良(liang)(liang)制(zhi)造平臺精心(xin)打造,豐富的(de)產(chan)品(pin)線,增強了企(qi)(qi)業(ye)抗風(feng)險(xian)能力。
每(mei)條生產線均具備高兼容性(xing)和(he)互換性(xing)的(de)精良配(pei)置,在PMC部對供(gong)、產、銷的(de)動態管(guan)理下(xia),可根據市場(chang)反饋,實現迅速換線、換品種生產,提高了企業(ye)的(de)應變能力(li)。
公(gong)(gong)(gong)司(si)(si)(si)控(kong)(kong)股(gu)股(gu)東為(wei)(wei)積華(hua)藥業(ye)(ye)有(you)限(xian)公(gong)(gong)(gong)司(si)(si)(si)(49%),積華(hua)藥業(ye)(ye)有(you)限(xian)公(gong)(gong)(gong)司(si)(si)(si)為(wei)(wei)在(zai)香港注冊成(cheng)立的有(you)限(xian)公(gong)(gong)(gong)司(si)(si)(si),主要從(cong)事投(tou)(tou)資(zi)控(kong)(kong)股(gu)業(ye)(ye)務。其他(ta)主要股(gu)東為(wei)(wei):云南(nan)(nan)醫(yi)藥工業(ye)(ye)股(gu)份有(you)限(xian)公(gong)(gong)(gong)司(si)(si)(si)(21%),云南(nan)(nan)醫(yi)藥工業(ye)(ye)股(gu)份有(you)限(xian)公(gong)(gong)(gong)司(si)(si)(si)為(wei)(wei)云南(nan)(nan)省(sheng)國資(zi)委轄下(xia)的醫(yi)藥有(you)限(xian)公(gong)(gong)(gong)司(si)(si)(si)。光(guang)控(kong)(kong)遠創(chuang)醫(yi)藥投(tou)(tou)資(zi)有(you)限(xian)公(gong)(gong)(gong)司(si)(si)(si)(11.16%),其是中國光(guang)大(da)控(kong)(kong)股(gu)有(you)限(xian)公(gong)(gong)(gong)司(si)(si)(si)下(xia)屬(shu)(shu)的境外投(tou)(tou)資(zi)控(kong)(kong)股(gu)公(gong)(gong)(gong)司(si)(si)(si),從(cong)事投(tou)(tou)資(zi)業(ye)(ye)務。成(cheng)都光(guang)控(kong)(kong)世紀(ji)醫(yi)療(liao)健康創(chuang)業(ye)(ye)投(tou)(tou)資(zi)有(you)限(xian)公(gong)(gong)(gong)司(si)(si)(si)(5.58%),其是中國光(guang)大(da)控(kong)(kong)股(gu)有(you)限(xian)公(gong)(gong)(gong)司(si)(si)(si)下(xia)屬(shu)(shu)的境內投(tou)(tou)資(zi)控(kong)(kong)股(gu)公(gong)(gong)(gong)司(si)(si)(si),主要從(cong)事創(chuang)業(ye)(ye)投(tou)(tou)資(zi)業(ye)(ye)務。